Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation
Galya Vassileva(Merck & Co., Inc., Rahway, NJ, USA (United States)), Eric L. Gustafson(Functional Technologies (United Kingdom)), Ming Zeng(AIL Research (United States)), Harry R. Davis(AIL Research (United States)), Joseph A. Hedrick, Susan J. Abbondanzo(Merck & Co., Inc., Rahway, NJ, USA (United States)), Lisa Markowitz(Functional Technologies (United Kingdom)), Nicholas Murgolo(Merck & Co., Inc., Rahway, NJ, USA (United States)), Andrei Golovko(AIL Research (United States)), Kevin N. Keane(Drug Safety Research Unit), Lizbeth Hoos(AIL Research (United States)), Shijun Yang(Functional Technologies (United Kingdom)), Diane Levitan, Glen Tetzloff(AIL Research (United States))
Cited by 272
Related Papers
Antibiotic Susceptibility Profiles of <i>Escherichia coli</i> Strains Lacking Multidrug Efflux Pump Genes
|Antimicrobial Agents and Chemotherapy|2001|502
Selective small-molecule inhibition of an RNA structural element
|Nature|2015|419
The Reduced Expression of 6ckine in the <i>plt</i> Mouse Results from the Deletion of One of Two 6ckine Genes
|The Journal of Experimental Medicine|1999|215